Matsumoto Mitsuyuki, Straub Richard E, Marenco Stefano, Nicodemus Kristin K, Matsumoto Shun-Ichiro, Fujikawa Akihiko, Miyoshi Sosuke, Shobo Miwako, Takahashi Shinji, Yarimizu Junko, Yuri Masatoshi, Hiramoto Masashi, Morita Shuji, Yokota Hiroyuki, Sasayama Takeshi, Terai Kazuhiro, Yoshino Masayasu, Miyake Akira, Callicott Joseph H, Egan Michael F, Meyer-Lindenberg Andreas, Kempf Lucas, Honea Robyn, Vakkalanka Radha Krishna, Takasaki Jun, Kamohara Masazumi, Soga Takatoshi, Hiyama Hideki, Ishii Hiroyuki, Matsuo Ayako, Nishimura Shintaro, Matsuoka Nobuya, Kobori Masato, Matsushime Hitoshi, Katoh Masao, Furuichi Kiyoshi, Weinberger Daniel R
Drug Discovery Research, Astellas Pharma Inc., Tsukuba, Ibaraki 305-8585, Japan.
Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6133-8. doi: 10.1073/pnas.0710717105. Epub 2008 Apr 14.
The G protein-coupled receptor (GPCR) family is highly diversified and involved in many forms of information processing. SREB2 (GPR85) is the most conserved GPCR throughout vertebrate evolution and is expressed abundantly in brain structures exhibiting high levels of plasticity, e.g., the hippocampal dentate gyrus. Here, we show that SREB2 is involved in determining brain size, modulating diverse behaviors, and potentially in vulnerability to schizophrenia. Mild overexpression of SREB2 caused significant brain weight reduction and ventricular enlargement in transgenic (Tg) mice as well as behavioral abnormalities mirroring psychiatric disorders, e.g., decreased social interaction, abnormal sensorimotor gating, and impaired memory. SREB2 KO mice showed a reciprocal phenotype, a significant increase in brain weight accompanying a trend toward enhanced memory without apparent other behavioral abnormalities. In both Tg and KO mice, no gross malformation of brain structures was observed. Because of phenotypic overlap between SREB2 Tg mice and schizophrenia, we sought a possible link between the two. Minor alleles of two SREB2 SNPs, located in intron 2 and in the 3' UTR, were overtransmitted to schizophrenia patients in a family-based sample and showed an allele load association with reduced hippocampal gray matter volume in patients. Our data implicate SREB2 as a potential risk factor for psychiatric disorders and its pathway as a target for psychiatric therapy.
G蛋白偶联受体(GPCR)家族高度多样化,参与多种形式的信息处理。SREB2(GPR85)是整个脊椎动物进化过程中最保守的GPCR,在表现出高度可塑性的脑结构中大量表达,例如海马齿状回。在此,我们表明SREB2参与确定脑大小、调节多种行为,并可能与精神分裂症易感性有关。SREB2的轻度过表达导致转基因(Tg)小鼠脑重量显著减轻、脑室扩大以及出现类似精神疾病的行为异常,例如社交互动减少、感觉运动门控异常和记忆受损。SREB2基因敲除(KO)小鼠表现出相反的表型,脑重量显著增加,同时有记忆增强的趋势,且无明显的其他行为异常。在Tg和KO小鼠中,均未观察到脑结构的明显畸形。由于SREB2 Tg小鼠与精神分裂症之间存在表型重叠,我们探寻两者之间可能的联系。位于内含子2和3'非翻译区(UTR)的两个SREB2单核苷酸多态性(SNP)的次要等位基因,在基于家系的样本中过度传递给精神分裂症患者,并显示出等位基因负荷与患者海马灰质体积减少相关。我们的数据表明SREB2是精神疾病的潜在危险因素,其信号通路可作为精神疾病治疗的靶点。